Lupin enters into research collaboration with CSIR-NCL and DST

For development of a continuous manufacturing process for biosimilar monoclonal antibody therapeutic

Lupin announced the signing of an agreement with CSIR-National Chemical Laboratory (CSIR-NCL, Pune) and Department of Science and Technology, (DST, Delhi) for conducting research on a continuous purification process development of a biosimilar monoclonal antibody therapeutic.

Powered by Capital Market - Live News